Results 231 to 240 of about 34,211 (250)
Mitochondria as subcellular targets for clinically useful anthracyclines
Advanced Drug Delivery Reviews, 2001 Due to the widespread use of anthracyclines as antitumor agents, a large number of investigations have been reported analyzing clinical and molecular aspects of these quinone antibiotics.
Klaus Jung
exaly +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming
Molecular Aspects of Medicine, 2023Roberto Mattioli +2 more
exaly
Anthracyclines in the treatment of early breast cancer friend or foe?
Breast, 2022Fátima Cardoso, Ana Tečić Vuger
exaly
Anthracyclines during pregnancy: embryo–fetal outcome in 160 patients
Annals of Oncology, 2004François Goffinet +2 more
exaly
Phase II study of pemetrexed in breast cancer patients pretreated with anthracyclines
Annals of Oncology, 2003Miguel Martin, M Namer, Marc Spielmann
exaly
Anthracyclines as Topoisomerase II Poisons: From Early Studies to New Perspectives
International Journal of Molecular Sciences, 2018Jessica Marinello, Giovanni Capranico
exaly
Anthracyclines potentiate anti-tumor immunity: A new opportunity for chemoimmunotherapy
Cancer Letters, 2015Pin Wu, Zhigang Zhang
exaly
Anthracyclines and ellipticines as DNA-damaging anticancer drugs: Recent advances
Pharmacology & Therapeutics, 2012Marie Stiborová +2 more
exaly